/

Società

Ce

Non verificato

Cellenkos, Inc.

Di cosa scriviamo

AgricolturaEcologia/Salute ambientaleFitnessMedicina - VarieSalute

3 comunicati stampa

Guarda tutti i comunicati

Press Release cover image

04/05/2026

Salute

Fitness

Medicina - Varie

Ecologia/Salute ambientale

Agricoltura

Cellenkos Announces FDA Clearance of Investigational New Drug (IND) Application for Phase 1b/ 2a Trial of CK0802 in Steroid-Refractory Graft-versus-Host Disease (GVHD)

Fonte

Cellenkos, Inc.

Emittente

1.00

0

Press Release cover image

27/04/2026

Salute

Fitness

Medicina - Varie

Ecologia/Salute ambientale

Agricoltura

Cellenkos, Inc. Announces FDA Clearance to Initiate Phase 2 Clinical Trial of CK0801 (Allogeneic Cord Blood-Derived Tregs) for Aplastic Anemia

Fonte

Cellenkos, Inc.

Emittente

1.00

0

22/05/2025

Farmaceutica

Sanità

Economia

Brevetti, marchi e copyright

Biologia

Cellenkos Inc. and King Faisal Specialist Hospital & Research Centre, Sign Strategic MOU to Advance T Regulatory Cell Therapies for Unmet Diseases

Fonte

Cellenkos, Inc.

Emittente

1.00

0

Seguaci

0

Compatibilità

0